1-866-877-2053 |
 |
The Clinician - Hospice Pharmacy Newsletter
To help keep our hospice partners up-to-date on clinical issues, we publish a quarterly newsletter, The Clinician, designed specifically to address current and relevant hospice pharmacy and drug topics. Listed below are links to download current and past issues in pdf format. Newsletters are listed by date and the main topic(s) covered. Please feel free to contact us for more information.
Guidelines for Covered Medications in Hospice Patients
Management of COPD in Hospice
Medication Management of COPD in Hospice
Resipratory Drugs: cost comparison
Dyspnea Management
ABH Topical Gel Ineffective?
Drug Shortage Problems
Fentanyl Nasal Spray: Lazanda
Antidepressants Not Effective in Dementia Patients
REMS: Update on Opioid Risk Evaluation & Mitigation Strategies
Roflumilast: New Drug Review
End Stage Dementia and the Role of Drug Treatment
GnRH Analogs and Advanced Prostate Cancer
Medical Marijuana and Hospice
Exalgo: old drug, new dosage-form
Pediatric Palliative Care, Part 3: Palliative Symptom Management
Sublingual nitroglycerin: proper use
Pediatric Palliative Care, Part 2: Pain Management
Pediatric Palliative Care, Part 1: Current Concepts in Drug Therapy
Morphine and Renal Impairment
Drug Disposal Guidelines (Latest FDA update)
Dementia Drugs Linked to Serious Adverse Events
Onsolis: a new fentanyl dosage-form
FDA’s Opioid Risk Evaluation & Mitigation Strategies (REMs)
FDA Reviews Acetaminophen Toxicity
Baclofen for Cancer Pain
New Drug: Tapentadol (Nucynta)
Plavix and PPI Drug Interaction (re-visited)
JCAHO’s National Patient Safety Goal on Anticoagulation:How does this Affect Hospice?
Drug Shortages: Morphine, Oxycodone, Hydromorphone
Statins Offer No Protection from Dementia
DEA Actions May Compromise Patients in SNFs
New On-line Education Course: Drugs, Delirium, and the Hospice Patient
Problems with Plavix and the PPI’s
Some New Drugs Approved in 2008
Subutex and Suboxone for Severe Pain
Discontinuing Drugs: Which Ones Need to be Taperred?
